share_log

Cibus to Participate in the 13th Annual Roth Technology Conference

Cibus to Participate in the 13th Annual Roth Technology Conference

Cibus将参加第十三届罗思科技会议
GlobeNewswire ·  11/18 07:00

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will participate in the 13th Annual Roth Technology Conference.

圣地亚哥,2024年11月18日(环球新闻社)--Cibus, Inc.(纳斯达克:CBUS)(以下简称“公司”),一家领先的农产品技术公司,开发和许可种子公司用于版税的植物特性,今天宣布,联合创始人、首席执行官和董事长Rory Riggs将参加第13届罗斯科技大会。

The conference is being held in New York City on November 19-20, 2024. Cibus is available for meetings on both days of the conference. Conference attendees should reach out to the Company or their conference host representative to schedule.

该会议将于2024年11月19-20日在纽约市举行。 Cibus在会议的两天都可以安排会议。 与会者应与公司或他们的会议主持代表联系以安排会议。

About Cibus

关于Cibus

Cibus is a leading independent plant trait company that develops and licenses plant traits to seed companies for royalties. Cibus is not a seed company, but rather a technology company that uses its proprietary gene editing technology to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus' strategy is focused on commercializing productivity traits for the world's major row crops with large acreage such as: canola, rice, soybean, corn and wheat. The Company targets traits that help manage farmers' seed productivity, economics and sustainability challenges such as weeds, disease, and insects. The United Nations estimates that the impacts from these challenges cost the global economy approximately $300 billion annually. Cibus has a current portfolio of six traits, three of which are in commercial development and four of which are multi-crop traits associated with weed management and disease, including Sclerotinia resistance and a new weed management trait which are in advanced greenhouse and field trial stages.

Cibus是一家领先的独立植物性状公司,开发并许可植物性状给种子公司以获取特许权使用费。Cibus不是一家种子公司,而是一家科技公司,利用其专有的基因编辑技术,以传统育种所需的极少时间和成本开发和商业化植物性状。Cibus的策略集中于商业化世界主要作物的生产力性状,这些作物有大片种植面积,如:油菜、稻米、大豆、玉米和小麦。该公司针对性状,帮助管理农民的种子生产力、经济性和可持续性挑战,如杂草、疾病和昆虫。联合国估计,这些挑战对全球经济的影响每年约为3000亿美金。Cibus目前拥有六个性状的组合,其中三个已经进入商业开发阶段,四个是与杂草管理和疾病相关的多作物性状,包括白粉病支撑位和一种新的杂草管理性状,目前正处于先进的温室和田间试验阶段。

CIBUS CONTACTS:

CIBUS联系方式:

INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636

投资者关系
Karen Troeber
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

Jeff Sonnek - ICR
jeff.sonnek@icrinc.com

MEDIA RELATIONS
media@cibus.com

媒体关系
media@cibus.com

Colin Sanford
colin@bioscribe.com
203-918-4347

Colin Sanford
colin@bioscribe.com
203-918-4347


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发